INDUSTRY INSIGHTS

Vaccination improves livability and performance in commercial flocks affected by necrotic enteritis

Commercial trials have demonstrated the efficacy of AVERT® NE from Huvepharma against necrotic enteritis in commercial broiler facilities. David Smith, DVM, MS, Director of Poultry Technical Services at Huvepharma discussed these trials, which evaluated livability and zootechnical performance of birds given the vaccine, pointing to improvements in vaccinated flocks compared to unvaccinated birds.

HOUSING

ABSTRACTS & POSTERS

HEALTH

Novel PCR assay differentiates among aMPV subtypes in single test

In the poultry sector, avian metapneumovirus (aMPV) infections can lead to severe economic repercussions, manifesting as drops in egg production and increased mortality, which lead to costly veterinary interventions and biosecurity measures. Researchers described the development of an assay, which was found to be capable of concurrently detecting and distinguishing among aMPV-A, aMPV-B and aMPV-C.

TURKEYS

Serological survey unveils emergence, trends of aMPV in Georgia

Avian metapneumovirus has not been detected in the US since the 1990s. So, it was a surprise in 2023 when cases began surfacing in Virginia, West Virginia and North Carolina. By January 31, 2024, the Georgia Poultry Laboratory Network received its first suspect case. Here’s what they did.

LAYERS

Multi-strain bacterin vaccine demonstrates broad protection against spotty liver disease

Recently, Campylobacter hepaticus was identified as the causative agent for chicken spotty liver disease (SLD), an illness which manifests as acute infectious hepatitis and causes a significant drop in egg production and high mortality in layer chickens. Researchers from Iowa State University, led by Orhan Sahin, DVM, PhD, are studying Campylobacter bacterins in the control of SLD.

BREEDERS

FEED